RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 
  • Regulatory NewsRegulatory News

    EMA to Cease Printing and Dispatching of CPPs During Relocation to Permanent Building

    As the European Medicines Agency (EMA) relocates within Amsterdam, the agency said on Tuesday that it will temporarily cease its printing and dispatching of Certificates of Pharmaceutical Products (CPPs) from 13 December until 18 January 2020. CPPs confirm the marketing authorization status of products authorized through the centralized procedure and they confirm compliance with good manufacturing practices. The temporary halt is occurring because of the agency’s rel...
  • Regulatory NewsRegulatory News

    EMA Launches Operations in Amsterdam

    The European Medicines Agency (EMA) on Monday kicked off operations at its temporary premises at the Spark building in Amsterdam Sloterdijk after moving out of its Canary Wharf office in London on 1 March.   EMA says it is also working with Dutch authorities to finish readying its temporary premises ahead of 30 March, when the agency’s seat officially switches from London to Amsterdam.   “By Monday 18 March, when EMA will be settled in the Spark building, close to ...
  • Regulatory NewsRegulatory News

    EMA Updates on Priorities Ahead of Netherlands Move

    Two months out from when the UK will officially exit the EU, the European Medicines Agency (EMA) on Wednesday provided an update on its move to the Netherlands and clarified its priorities in the new year.   With the anticipated loss of 25% of its staff , EMA says it must continue to prioritize its activities according to its business continuity plan (BCP) through at least the first half of 2019.   "The focus will be on the authorization, maintenance and supervi...
  • Regulatory NewsRegulatory News

    EMA: Amsterdam HQ Won't Be Ready in Time for Move

    The European Medicines Agency (EMA) on Friday said that its new headquarters in Amsterdam will not be complete until November 2019, eight months after the agency must move from its current offices in London. EMA's Management Board was briefed on the agency's relocation plans at its meeting earlier this week, and said it was pleased with accommodations offered by the Dutch government. The announcement comes less than a month after the European Council chose Amsterdam t...
  • Regulatory NewsRegulatory News

    EMA Headquarters to Move to Amsterdam

    The European Council on Monday voted to move the European Medicines Agency’s (EMA) headquarters and nearly 900 staffers from London to Amsterdam – a move decided in a runoff. The transition is expected to begin tomorrow and finish 30 March 2019. The decision was made by closed ballot votes from each EU member state and is the result of the UK’s decision to leave the EU. The decision followed bids put forth by 19 cities in the EU to be the new host. "Amsterda...
  • Regulatory NewsRegulatory News

    EMA Warns of Major Staff Losses in HQ Relocation

    The European Medicines Agency (EMA) on Tuesday warned that it could lose a majority of its staff based on which of the 19 cities vying to host the medicines regulator is selected by the European Council in November. Based on the results of a survey completed by 92% of EMA's staff earlier this month, the agency says it could lose between 19% and 94% of its staff depending on which city is selected as its future host. "For certain locations staff retention rates could be ...
  • Regulatory NewsRegulatory News

    19 European Cities Vie to Host EMA Headquarters

    The European Commission on Tuesday said it will assess the 19 offers from EU cities to host the European Medicines Agency's (EMA) headquarters as it moves from London's Canary Wharf following Britain's decision to leave the EU. The Commission's assessment will be published online 30 September 2017, then the European Council will have a political discussion based on the assessment at the General Affairs Council (Article 50 format) in October 2017. The vote will cons...
  • Regulatory NewsRegulatory News

    Decision on EMA Relocation Set for November, Council Agrees on Bidding Procedure

    At the EU Summit in Brussels on Thursday, the European Council backed a procedure to determine where the European Medicines Agency (EMA) will be relocated to following the UK's withdrawal from the EU. And, while previous reports had indicated the decision on where EMA will end up would be made by October 2017, the procedure adopted by the Council instead calls for a vote by the 27 EU member states, minus the UK (EU27), in November to give more time for member states to...